Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-062263
Date:2021-10-28
Issuer: CRINETICS PHARMACEUTICALS, INC. (CRNX)
Original Submission Date:

Reporting Person:

MADAN AJAY
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-10-28 M 106,383 a $0.73 184,671 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.73 2021-10-28 deemed execution date M 106,383 (d) 2028-03-16 common stock 106,383 $0.73 0 direct
Footnotes
IDfootnote
f1 includes 772 shares acquired under the issuer's employee stock purchase plan since the last section 16 filing by the reporting person.
f2 25% of the shares subject to the option vested on july 17, 2017 and 1/48th of the total remaining number of shares subject to the option vest monthly thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date.
WhaleWisdom Logo

Elevate your investments